Tag: Pre-Grant Opposition

Pre-grant opposition filed against Indian Patent Application no. 201721030943 dismissed

Recently, Khurana and Khurana Advocates and IP Attorney’s Patents team was successful in defending a pre-grant opposition filed to reject our client’s Indian Patent Application no. 201721030943. The application was opposed on grounds of lack of clarity and sufficiency of disclosure, lack of novelty, lack of inventive step, non-patentable subject matter under section 3(d), 3(f) … Continue reading Pre-grant opposition filed against Indian Patent Application no. 201721030943 dismissed

Read more »

Patent Application Refused On Grounds Of Insufficiency Of Disclosure

In a recent patent pre-grant opposition matter wherein Khurana and Khurana, Advocates and IP Attorneys (K&K) represented the Opponent, the patent application was refused mainly on grounds of Insufficiency of Disclosure as per Section 25(1)(g) of the Indian Patents Act, 1970 (“Patents Act”). This case re-confirms the role of sufficiency of disclosure or enablement during … Continue reading Patent Application Refused On Grounds Of Insufficiency Of Disclosure

Read more »

Sofosbuvir: The Next Pre-Grant Opposition Target by I-MAK

After anti–influenza drug Tamiflu (Oseltamivir Phosphate) and antiretroviral drug Viread, Gilead Sciences is again back in news, this time with its hepatitis C (HCV) drug Sofosbuvir. Like Tamiflu and Viread pre-grant opposition, Sofosbuvir patent application is also facing pre-grant opposition. Non-profit group I-MAK (Initiative for medicines access and knowledge) has filed a pre-grant opposition against … Continue reading Sofosbuvir: The Next Pre-Grant Opposition Target by I-MAK

Read more »

Draft Patents (Amendment) Rules 2013

Indian Patent Office (IPO) has recently published Draft Patents (Amendment) Rules 2013 here and has invited comments (objections or suggestions) from public within 45 days from the publication of the notification (12th June 2013). The main changes proposed are the following: 1. There is a 100% hike in official fees for almost all the proceedings … Continue reading Draft Patents (Amendment) Rules 2013

Read more »